Robin L. Blumenthal
Impact in
- Dermatology top 1%
- Dermatology and Skin Diseases
- Immunology and Allergy top 2%
- Allergic Rhinitis and Sensitization
- Food Allergy and Anaphylaxis Research
Papers in
-
- Dermatology and Skin Diseases 4
-
- Asthma and respiratory diseases 4
- Co-authors
- Kai W. Wucherpfennig (1 shared paper)Steven P. Balk (1 shared paper)Richard S. Blumberg (1 shared paper)Ellen C. Ebert (1 shared paper)Steven B. Landau (1 shared paper)Douglass W. Forsha (4 shared papers)Wynnis L. Tom (4 shared papers)Lee T. Zane (4 shared papers)
- Journals
- Journal of Allergy and Clinical Immunology (3 papers)The Journal of Immunology (2 papers)The American Journal of Gastroenterology (1 paper)British Journal of Clinical Pharmacology (1 paper)Clinical Therapeutics (1 paper)
- Partner nations
- United StatesIndonesiaBelgium
In The Last Decade
Robin L. Blumenthal
12 papers receiving 910 citations
Robin L. Blumenthal's Hit Papers
Peers
Comparison fields: 5 of 85
- Dermatology 376
- Immunology and Allergy 239
- Immunology 312
- Physiology 145
- Rheumatology 67
Countries citing papers authored by Robin L. Blumenthal
This map shows the geographic impact of Robin L. Blumenthal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin L. Blumenthal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin L. Blumenthal more than expected).
Fields of papers citing papers by Robin L. Blumenthal
This network shows the impact of papers produced by Robin L. Blumenthal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin L. Blumenthal. The network helps show where Robin L. Blumenthal may publish in the future.
Co-authors
The 25 scholars most cited alongside Robin L. Blumenthal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults Hit paper breakdown → | 2016 | 423 |
| 2 | 1991 | 206 | |
| 3 | 2000 | 77 | |
| 4 | 1998 | 69 | |
| 5 | 2001 | 65 | |
| 6 | 2010 | 38 | |
| 7 | 2011 | 26 | |
| 8 | 1996 | 22 | |
| 9 | 2016 | 3 | |
| 10 | 2008 | 3 | |
| 11 | Two phase 3 studies in atopic dermatitis with crisaborole, the novel, nonsteroidal topical phosphodiesterase 4 inhibitor | 2016 | 2 |
| 12 | 2016 | 1 |
About Robin L. Blumenthal
Robin L. Blumenthal is a scholar working on Dermatology, Physiology, Oncology, Immunology and Epidemiology, having authored 12 papers that have together received 935 indexed citations. Recurring topics across this work include Dermatology and Skin Diseases (4 papers), Asthma and respiratory diseases (4 papers), Mycobacterium research and diagnosis (2 papers), Urticaria and Related Conditions (2 papers), Immune Cell Function and Interaction (2 papers), Allergic Rhinitis and Sensitization (1 paper), Tuberculosis Research and Epidemiology (1 paper) and T-cell and B-cell Immunology (1 paper). The work is most often cited by research in Dermatology (376 citations), Immunology and Allergy (239 citations), Immunology (312 citations), Physiology (145 citations) and Rheumatology (67 citations). Robin L. Blumenthal has collaborated with scholars based in United States, Indonesia and Belgium. Frequent co-authors include Kai W. Wucherpfennig, Steven P. Balk, Richard S. Blumberg, Ellen C. Ebert, Steven B. Landau, Douglass W. Forsha, Wynnis L. Tom, Lee T. Zane, Mark Lebwohl and Amy S. Paller. Their work appears in journals such as Journal of Allergy and Clinical Immunology, The Journal of Immunology, The American Journal of Gastroenterology, British Journal of Clinical Pharmacology and Clinical Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.